MedPath

Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis

Phase 4
Completed
Conditions
C.Delivery; Surgery (Previous), Gynecological
Interventions
Registration Number
NCT02194855
Lead Sponsor
Fudan University
Brief Summary

The investigators investigated whether laparoscopic versus open surgical approaches affected the pharmacokinetic and pharmacodynamic of a single bolus dose of rocuronium or cisatracurium.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • American Society of Anesthesiology 1-2
  • BMI 18-30 kg.m-2
  • elective gynaecological operations under general anaesthesia
Read More
Exclusion Criteria
  • cirrhosis
  • hepatitis
  • hepatoma
  • heart failure
  • arrhythmia
  • renal dysfunction
  • electrolyte disturbances
  • acid-base imbalances
  • neuromuscular disorders
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laparoscopic operation on rocuroniumrocuroniumaccording different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.
conventional open surgery on cisatracuriumcisatracuriumaccording different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.
conventional open surgery on rocuroniumrocuroniumaccording different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.
laparoscopic operation on cisatracuriumcisatracuriumaccording different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.
Primary Outcome Measures
NameTimeMethod
the blood flow in the right and middle hepatic veinsup to 9 months

Measurements of the blood flow in the right and middle hepatic veins were performed at baseline and 1,5, 10, 20, 30min after insufflation of carbon dioxide or incise the skin as well as 1 and 5 min after deflation or close the wound.

Secondary Outcome Measures
NameTimeMethod
the plasma Concentration of rocuronium and cisatracuriumup to 9 months

Venous blood samples (3 ml) were taken 2 min prior to and at 5,30, 60 min following administration of rocuronium/cisatracurium.The aim of the present was to study the blood concentration of rocuronium/cisatracurium in laparoscopic surgery compared with conventional open gynaecological surgery

© Copyright 2025. All Rights Reserved by MedPath